SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PolyMedix
An SI Board Since April 2010
Posts SubjectMarks Bans Symbol
77 5 0 PYMX
Emcee:  tnsaf Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
77CTIX, another caveat. Lotsa options awarded to top management at bargain basemetuck-2/6/2014
76Re: CTIX partnering strategy. I could only find one reference, on a slide fromtuck-2/6/2014
75So, a year and a half later, another company (CTIX) is starting a P2b trial for tuck-2/6/2014
74Another defensin type antibiotic New Substance Kills Multiresistant Bacteria Wetnsaf-10/30/2013
73Buried in this SeekingAlpha article is an obituary for PYMX: seekingalpha.com Ttnsaf-9/17/2013
72Unless we're seeing a bad April Fool's joke, PYMX has filed for chapter tuck-4/1/2013
71PolyMedix Announces Results of Special Meeting, Effective Date of Reverse Stock tnsaf-3/20/2013
70PolyMedix plans reverse stock split PolyMedix has called a special meeting of itnsaf-3/7/2013
69PolyMedix Announces Proposed Public Offering of Common Stock RADNOR, Pa., Marctnsaf-3/7/2013
68PolyMedix Provides Business Update and Reports Fourth Quarter 2012 Financial Restnsaf-3/6/2013
67PolyMedix CEO Posts Letter to Shareholders on Its Website RADNOR, Pa., Feb. 7,tnsaf-2/13/2013
66PolyMedix Announces Departure of CEO, Appointment of Interim CEO RADNOR, Pa., tnsaf-2/5/2013
65 PolyMedix Engages Investment Banker, Amends Credit Facility RADNOR, Pa., Jan. tnsaf-1/24/2013
64PolyMedix Announces Successful Meeting With FDA for Brilacidin Meeting With FDAtnsaf-11/16/2012
63PolyMedix Reports Third Quarter 2012 Financial Results RADNOR, Pa., Nov. 8, 2tnsaf-11/9/2012
62PolyMedix Receives Grant From National Cancer Institute to Study Brilacidin for tnsaf-9/20/2012
61 PolyMedix Presents New Data on Its Defensin-Mimetic Antibiotics at 52nd Annual tnsaf-9/12/2012
60PolyCides Outperformed Triclosan as Active Antimicrobial Agent in Suture Coatingtnsaf-9/5/2012
59Class action suits, a cash balance of 12 million, and statements like " Pentuck18/12/2012
58 PolyMedix Reports Second Quarter 2012 Financial Results RADNOR, Pa., Aug. 9, tnsaf-8/12/2012
57PolyMedix and University of Pennsylvania Collaborate to Develop New Class of Deftnsaf-7/31/2012
56PolyMedix Receives USAN Approval for Generic Name of Brilacidin for PMX-30063 [gtnsaf-6/13/2012
55New Data on PMX-30063 Presented at ASCO Suggest Strong Potential as Treatment fotnsaf-6/4/2012
54PolyMedix's trading symbol has changed from PYMX.OB to PYMX.tnsaf-5/31/2012
53PolyMedix Provides Update on PMX-60056 Program [Finally, a decision to focus ontnsaf-5/11/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News